A message from General Atomics

Advanced Nuclear Fuel Cladding: Innovative Materials Enhance Fleet Safety and Performance

Lu-177 production begins at Canada’s Bruce NPP

November 1, 2022, 1:27PMNuclear News

Bruce's Unit 7 is now producing Lutetium-177, used in targeted cancer therapeutics. (Photo: Bruce Power)

An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich SE (ITM) announced they have begun commercial production of lutetium-177 using Unit 7 of the Bruce nuclear power plant in Kincardine, Ontario. According to the companies, this marks the first time a commercial power reactor has been used to commercially produce short-lived medical radioisotopes.

To continue reading, log in or create a free account!

Framatome, IBA to develop At-211 production network in Europe and U.S.

February 14, 2025, 7:00AMNuclear News

French nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the...

BWXT to acquire Kinectrics in “complementary” $525M deal

January 8, 2025, 12:01PMNuclear News

Nuclear manufacturer BWX Technologies has announced its plan to acquire Kinectrics Inc. for approximately $525 million. The deal is expected to close in mid-2025....

Framatome to produce Lu-177 at Romania’s Cernavoda

November 18, 2024, 9:30AMNuclear News

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at...

Accident tolerant fuel completes first lifecycle at Vogtle

October 25, 2024, 9:30AMNuclear News

Framatome’s enhanced accident tolerant fuel assemblies recently completed a third 18-month fuel cycle at Southern Nuclear’s Vogtle-2 plant—the first of this type of fuel to reach this...

NRC schedules Atlanta meeting

October 22, 2024, 7:01AMNuclear News

A hybrid public meeting hosted by the Nuclear Regulatory Commission on October 30 will feature chair Christopher Hanson and commissioners David Wright, Annie Caputo, and Bradley Crowell....

The DOE picks six HALEU deconverters. What have we learned?

October 9, 2024, 3:01PMNuclear News

The Department of Energy announced contracts yesterday for six companies to perform high-assay low-enriched uranium (HALEU) deconversion and to transform enriched uranium hexafluoride (UF6) to...

TerraPower reaches market-scale production of Ac-225

October 4, 2024, 9:30AMNuclear News

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the...

QSA Global, Niowave to collaborate on Ac-225 production using Ra-226

August 14, 2024, 3:28PMNuclear News

QSA Global, a provider of radioisotope products, and Niowave, a Michigan-based producer of medical radioisotopes, announced that the companies will codevelop a scalable radium purification...

Plans for the Bruce C project in Ontario open for public comment

August 14, 2024, 12:20PMNuclear News

As Bruce Power continues predevelopment work, public input is being sought on the potential Bruce C nuclear power expansion project in Ontario.Bruce Power recently submitted its initial...

Bruce Power refurbishment project ahead of schedule

August 8, 2024, 12:01PMNuclear News

Bruce Power has announced the completion of its Unit 3 reactor removal—a milestone on its Major Component Replacement (MCR) project aimed at extending the Bruce plant’s operational life...

Lu-177 production begins at Canada’s Bruce NPP

Related Articles